![Peter M. Elias](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter M. Elias
Director Técnico/Científico/I+D en Ceragenix Corp. .
Cargos activos de Peter M. Elias
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Ceragenix Corp. | Director Técnico/Científico/I+D | 01/05/2004 | - |
Historial de carrera de Peter M. Elias
Antiguos cargos conocidos de Peter M. Elias.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
OnSource Corp. | Director Técnico/Científico/I+D | - | 27/06/2005 |
Ceragenix Pharmaceuticals, Inc.
![]() Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO. | Director Técnico/Científico/I+D | 01/05/2005 | - |
Formación de Peter M. Elias.
Stanford University | Undergraduate Degree |
The University of California, San Francisco | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
Operativa
Chief Tech/Sci/R&D Officer | 3 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectorial
Consumer Services | 4 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 3 |
---|---|
OnSource Corp. | Consumer Services |
Ceragenix Pharmaceuticals, Inc.
![]() Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO. | Health Technology |
Ceragenix Corp. |
- Bolsa de valores
- Insiders
- Peter M. Elias
- Experiencia